29 November 2016

NICE, 10 Spring Gardens, London, SW1A 2BU

Final Agenda

The meeting will start promptly at 10:00 and is expected to finish at approximately 17:00.

Please note that this agenda is subject to change prior to the meeting.

  1. Welcome and introduction to format of meeting – Part 1 only (open session)
  2. Apologies – Part 1 only (open session)
  3. Any other business – Part 1 only (open session)
  4. Appraisal of everolimus for the second-line treatment of metastatic renal cell carcinoma (review of TA219) [ID1015]
    • 5.1. Declarations of interest – Part 1 only (open session)
    • 5.2. Introduction by the chair, Andrew Stevens Part 1 only (open session)
    • 5.3. Presentation by the chair, Andrew Stevens Part 1 AND part 2 (open and closed session)
    • 5.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  5. Appraisalof trastuzumab emtansine for the treatment of locally advanced or metastatic HER2-positive breast cancer after treatment with trastuzumab and a taxane (review of TA371) [ID1013]
    • 6.1. Declarations of interest – Part 1 only (open session)
    • 6.2. Introduction by the chair, Andrew Stevens Part 1 only (open session)
    • 6.3. Presentation by the chair, Andrew Stevens Part 1 AND part 2 (open and closed session)
    • 6.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  6. Appraisal of sorafenib for advanced hepatocellular carcinoma (review of TA189) [ID1012]
    • 8.1. Declarations of interest – Part 1 only (open session)
    • 8.2. Introduction by the chair, Amanda Adler – Part 2 only (closed session)
    • 8.3. Presentation by the chair, Amanda Adler  Part 1 AND 2 (open and closed session)
    • 8.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)

To print an agenda, please right click and select 'Print' from the menu.

Date, time and venue of next meeting

The next technology appraisal CDF committee meeting will take place at 10:00 on Wednesday 1 February 2017 at NICE, Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT.

Please note all timings are approximate.

How to register

  • Click on the register link below and complete the registration form, selecting the topics you would like to attend.
  • You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.
  • Registration will close on Tuesday 15 November 2016Please note that it may not be possible to accept late requests. 
  • Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Jon Littler.
  • Registrants wishing to conduct a research study on committee meetings and/or NICE processes will require prior permission. Contact the NICE Enquiry Handling team at nice@nice.org.uk.
  • Further information about conducting research is also available in our common questions and answers about meetings in public document.

 

Registration period: 01 to 15 November 2016
Registration is closed.